Table 1.
Baseline characteristics of patients who underwent pancreatic duct occlusion.
| Duct occlusion, =48 | Fistula, n = 31 | No fistula, n = 17 | p -value | |
|---|---|---|---|---|
| Age (yrs) | ||||
| Mean (± SD) | 62.79 (± 10.02) | 62.87 (± 8.23) | 62.65 (± 12.96) | 0.9429 |
| Median | 66.00 | 66.00 | 66.00 | |
| Range | (34–78) | (44–78) | (34–78) | |
| Gender, n (%) | ||||
| Male | 29 (60.4) | 22 (70.97) | 7 (41.18) | 0.0651 |
| Female | 19 (39.6) | 9 (29.03) | 10 (58.82) | |
| BMI | ||||
| Mean (± SD) | 25.27 (± 1.64) | 25 (± 1.54) | 25.51 (± 1.71) | 0.2968 |
| Median | 25 | 25 | 25 | |
| Range | (21–28) | 23–28 | 21–28 | |
| ASA, n (%) | ||||
| I | 1 (2.1) | 1 (3.24) | 0 (0) | 1.0000 |
| II | 16 (33.3) | 12 (38.71) | 4 (23.53) | 0.5316 |
| III | 19 (39.6) | 12 (38.71) | 7 (41.18) | 1.0000 |
| IV | 12 (25.0) | 6 (19.34) | 6 (35.29) | 0.3002 |
| Previous procedures, n (%) | ||||
| ERCP | 16 (33.3) | 14 (45.16) | 2 (11.76) | 0.486 |
| PTC stent | 2 (4.2) | 1 (3.22) | 1 (5.88) | 1.0000 |
| Colecistectomy | 1 (2.1) | 0 (0) | 1 (5.88) | 0.3673 |
| Comorbidities, n (%) | ||||
| Arterial hypertension Diabetes mellitus Atrial fibrillation HCV positive COPD Liver transplantation Cerebral ischemia |
16 (33.3) 10 (20.8) 6 (12.5) 3 (6.3) 3 (6.3) 1 (2.1) 1 (2.1) |
10 (32.26) 5 (16.13) 4 (12.90) 3 (9.68) 2 (6.45) 1 (3.22) 1 (3.22) |
6 (35.29) 5 (29.41) 2 (6.45) 0 (0) 1 (5.88) 0 (0) 0 (0) |
1.0000
0.2947 1.0000 0.5430 1.0000 1.0000 1.0000 |
| Pre-operative Ca19.9, U/ml | ||||
| Mean, (± SD) Median Range |
285.14 (± 660.83) 80.45 (1–2734.10) |
117.79 (±85.29) 80.45 (22.4–2431) |
787.2 (±1307) 206.85 (1–2734.10) |
0.0062 |
BMI, Body Mass Index; ERCP, Endoscopic Retrograde Cholangiopancreatography; PTC, Percutaneous Transhepatic Cholangiography; COPD, Chronic Obstructive Pulmonary Disease; Ca19.9, carbohydrate antigen 19–9 or cancer antigen 19–9 or sialylated Lewis.